Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

The primary purpose of the study is to assess the long term safety of intravitreal (IVT) injections of vonaprument.

Participants needed: 605
Trial details
Phase: Phase 3Age: 50+Biological sex: AllType: InterventionalSponsor: Annexon, Inc.Updated: Sep 8, 2026Locations: 7
Eligibility criteria

Participants with a diagnosis of dry AMD with GA who completed the Phase 3 ARCHE...

Any event or condition arising during the ARCHER II study that would put the par...

Status: Recruiting

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

The goal of this open label study is to measure pharmacokinetics, pharmacodynamics, early efficacy, and safety of tanruprubart in adult and pediatric participants, in the United States, Canada, and Europe.

Participants needed: 30
Trial details
Phase: Phase 3Age: 12-85Biological sex: AllType: InterventionalSponsor: Annexon, Inc.Updated: May 28, 2026Locations: 13
Eligibility criteria

Diagnosis of GBS according to the National Institute of Neurological Disorders a... [+2]

Previous or intended treatment with either plasma exchange or IV immunoglobulin... [+1]